SKI Market

Indian Indices

Nifty

26,068.15 -124.00
(-0.47%)

Sensex

85,231.92 -400.76
( -0.47%)

Bank Nifty

58,867.70 -480.00
( -0.81%)

Nifty IT

36,885.35 -157.95
( -0.43%)

Global Indices

Nasdaq

46,275.21 501.96
(1.10%)

Dow Jones

6,624.30 64.54
(0.98%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,535.95 8.30
(0.09%)

Forex

USD-INR

88.67 0.16
(0.19%)

EUR-INR

102.19 -0.14
(-0.14%)

GBP-INR

115.88 -0.12
(-0.10%)

JPY-INR

0.56 0.00
(-0.65%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Valiant Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543998

INE0JWS01017

58.4359033

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VALIANTLAB

57.94

396.48

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

RBL Bank consolidated net profit declines 16.94% in the September 2025 quarter

Oct 20,2025

Net profit of RBL Bank declined 16.94% to Rs 192.46 crore in the quarter ended September 2025 as against Rs 231.70 crore during the previous quarter ended September 2024. Total Operating Income declined 0.65% to Rs 3507.92 crore in the quarter ended September 2025 as against Rs 3531.02 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Total Operating Income	3507.92	3531.02	-1
OPM %	36.14	36.60	-
PBDT	245.17	304.49	-19
PBT	245.17	304.49	-19
NP	192.46	231.70	-17

26,068.15 -124.00 (-0.47%)

85,231.92 -400.76 ( -0.47%)

58,867.70 -480.00 ( -0.81%)

36,885.35 -157.95 ( -0.43%)

46,275.21 501.96 (1.10%)

6,624.30 64.54 (0.98%)

48,653.14 -1,170.80 (-2.35%)

9,535.95 8.30 (0.09%)

88.67 0.16 (0.19%)

102.19 -0.14 (-0.14%)

115.88 -0.12 (-0.10%)

0.56 0.00 (-0.65%)